NHI Q1 Normalized FFO $1.12/share vs $1.11 YoY; full-year guidance raised

NATIONAL HEALTH INVESTORS INC

2024-Q1 EPS reported $0.71 revenue$81,513,000

Q1 diluted EPS $0.71 (vs $0.79); NAREIT FFO $1.10 (vs $1.16); Normalized FFO $1.12 (vs $1.11).
Full-year 2024 guidance raised: NAREIT FFO $4.36-$4.41; Normalized FFO $4.37-$4.43; Normalized FAD $196.7-$199.2M.
Collected $2.3M deferred rent in Q1; Bickford annual rent reset to $34.5M up from $31.4M.
SHOP NOI $2.9M (+$1.0M YoY); occupancy at SLC 83.1%, Bickford 85.8%, SHOP 86.3% in March.
Net debt $1.1B; leverage 4.4x; $25M board-approved capex at ~8% yield; pipeline >$300M with LOIs >$100M at >8%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NATIONAL HEALTH INVESTORS INC reported three months ended March 31, 2024 results: EPS $0.71. Guidance raised.

Period: three months ended March 31, 2024
EPS: $0.71
Guidance: raised
Result: reported results

Exact text from the filing

Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2024 was $0.71 compared to $0.79 during the same period in the prior year.

View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

NATIONAL HEALTH INVESTORS INC filing history →

Source: SEC EDGAR

accession 0000877860-24-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.